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Background: The incidence of CVD is decreasing in spite of increasing BMI in the population. We examined trends in
metabolic health among overweight and obese individuals and the influence of lifestyle and socioeconomic status. Six
cross sectional population surveys in the Northern Sweden MONICA Study between 1986 and 2009. 8 874 subjects 25 to
64 years participated (74% participation rate). Metabolic health was defined as a total cholesterol level below 5.0 mmol/l,
blood pressure below 140/90 mmHg and not having diabetes. In 2009 the age span 25 to 74 years was studied.
Results: The prevalence of metabolic health among obese subjects increased by 7.9 % per year (95% confidence interval
5.4; 10.5), reaching 21.0% in 2009. The corresponding figures for overweight subjects were 5.9% per year (4.6; 7.3),
reaching 18% in 2009, whereas for the normal-weight subjects, the increase was 6.2% per year (5.3; 7.2), reaching 39% in
2009. The prevalence of metabolic health among subjects with abdominal obesity increased by 5.8% (4.6; 7.0) per year,
reaching 17.3% in 2009. Among those with no abdominal obesity the increase was 6.2% (5.2; 7.1), reaching 38% in 2009
(p = <0.001 for all groups). Only among non-obese men and obese women did the increase continue between 2004 and
2009. In the other groups a slight decline or levelling off was noted.
In 2009 women had a 27% higher prevalence of metabolic health than men. The prevalence of metabolic health among
the obese was 19.8% which declined to 15.8% if subjects treated for hypertension or hypercholesterolemia were
classified as not healthy. Overweight and obese subjects were less often metabolically healthy (odds ratio 0.54 and 0.59
respectively) compared with normal-weight subjects, independent of sex and age as were subjects with abdominal
obesity (odds ratio 0.52). Adjustments for smoking, physical activity and education level did not influence any estimates.
Conclusions: This report shows a large increase in prevalence of metabolic health from 1986 to 2009 for all
anthropometric categories. Metabolic health remains considerably less prevalent among overweight and obese subjects
than among those with normal weight.
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While the number of obese and overweight people con-
tinuously increases, the incidence of cardiovascular disease
(CVD) as a whole is decreasing [1-5]. In Sweden, all CVD
risk factors, exempting obesity [6] and diabetes are de-
creasing [7]. Recent investigations into the obese and over-
weight population of Sweden have shown that overweight
does not lead to increased mortality [8,9], and a recent
meta-analysis with a sample of almost 3 billion people* Correspondence: mats.eliasson@nll.se
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unless otherwise stated.extended these findings to subjects with BMI 30–35 as
well [10]. However, this has been contradicted in other
studies, which have shown an increased mortality for
obese individuals [11-13].
It has been suggested that within the obese population
there is a subgroup of subjects that lack the clustering of
risk factors seen in the obese population in general, and
these “healthy obese” will have less risk for CVD [14-16]
although a recent systematic review disputed this [17].
Increased cardiovascular fitness (“fat but fit”) and differ-
ences in socioeconomic factors, such as living conditions
and education levels, have been suggested as explana-
tions [18-21]. It is also possible that a previously highal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in parallel with, or even more so than, the decrease in
the general population. No repeated cross-sectional
population based studies has been published, to the best
of our knowledge.
In this paper we report time trends over 23 years in
the population of northern Sweden in the prevalence of
metabolic health in obese and overweight versus
normal-weight individuals, as well as in people with or
without abdominal obesity. Further, we explore if phys-
ical activity, smoking and education modify the effect of
obesity on metabolic cardiovascular risk factors.
Methods
The Northern Sweden MONICA study conducted six
population based surveys between 1986 and 2009 [7].
For each survey 250 men and 250 women from each 10-
year age group were randomly sampled from population
registers. For the time trend analysis we used ages 25–64
years and for the analysis of predictors in 2009 we used
25–74 years. Details on sampling, selection and meas-
urement methods [22], and data on non-participants [7]
have been described previously.
The procedures were standardized across surveys.
Subjects wore light clothes and no shoes. Weight was
measured to the nearest 0.2 kg, and height to the nearest
cm [3]. Waist circumference was measured midway
between the lower rib margin and the iliac crest. Until
1994, a daily-calibrated balance scale was used, and from
1999 and onwards, an electronic scale was used.
Regarding physical activity, subjects were divided into
two groups based on whether they performed at most
two light walks per month or more frequent physical
exercise. Subjects were divided by educational level into
two groups based on whether they had any university
level education or at most, secondary or vocational
school education. Subjects who answered yes to the
question “Do you have diabetes mellitus?” in the ques-
tionnaire were classified as having “known diabetes”.
Normal weight was defined as body mass index (BM)I
< 25, overweight as BMI between 25 and 30, and obesity
as BMI > 30. Abdominal obesity was defined as a waist
circumference > 94 cm for men and >80 cm for women.
A metabolically healthy individual, designated also as
having metabolic health, was defined as not having
hypertension or hypercholesterolemia, using cut-offs
proposed by the Fifth Joint Task Force of the European
Society of Cardiology and other experts on cardiovascu-
lar disease prevention in clinical practice [23]. These
levels were blood pressure <140/90 mmHg, total choles-
terol <5.0 mmol/l, and no known diabetes, irrespective
of treatment with anti-hypertensives or lipid-lowering
agents. In an ancillary analysis only subjects without
such treatment were classified as metabolically healthy.MONICA is covered by multiple ethical permissions
from The Regional Ethical Review Board, Umeå, Sweden,
the latest in 2008. All participants gave written consent.
Statistical analysis
Statistical significance of differences between anthropo-
metric groups was tested using x2-tests where the vari-
ables were categorical and ANOVA where the variable
were on a continual scale. Generalized linear models and
logistic regression were used to adjust for differences in
age and sex between groups and to calculate annual per-
cent change. Time trends in the prevalence of metabolic
health were analysed by linear-by-linear x2-tests. Confi-
dence intervals (CI) are 95%.
Results
Trends in metabolic health according to BMI
Altogether 8 874 subjects aged 25 to 64 years partici-
pated in the six population surveys 1986 to 2009, 74% of
those invited. The prevalence of obese subjects with
metabolic health increased by 7.9 % (95%CI 5.4; 10.5)
per year, reaching 21.0% (95%CI 17; 26) in 2009. The
corresponding increase for overweight subjects were
5.9% (4.6; 7.3) per year, reaching 18% (15; 22) in 2009,
and the increase was 6.2% (5.3; 7.2) per year among
normal-weight subjects, reaching 39% (35; 43) in 2009
(p = <0.001 for each group; Figure 1a). Among normal-
weight and overweight subjects a slight decrease in the
prevalence of metabolic health was noted between 2004
and 2009. There was no interaction between survey year
and BMI category.
In normal-weight men the prevalence of metabolic
health increased approximately linearly, but this trend
was attenuated for the overweight men and decreased
for the obese between 2004 and 2009 (Figure 1b). The
overweight women had a lower prevalence of metabolic
health than the obese in 1986, 1994 and 2009 (Figure 1c).
In normal-weight and obese women, but not overweight
women, the prevalence of metabolic health decreased
between 2004 and 2009. Time trends were highly signifi-
cant for all sex and BMI categories (p < 0.001).
Trends in metabolic health according to waist
circumference
The prevalence of individuals with abdominal obesity
who were metabolically healthy increased by 5.8% (CI
4.6; 7.0) per year, reaching 17.3% (15; 20) in 2009.
Among those with no abdominal obesity the increase
was 6.2% (CI 5.2; 7.1), reaching 38% (34; 42) in 2009
(Figure 2a). Both in subjects with or without abdom-
inal obesity there was an increase in metabolic health
up to 2004, and thereafter a decline. Similar results
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Figure 1 Time trends in metabolic health for subjects aged 25–64, by BMI-category; a) the whole population; b) men; c) women.
Normal-weight (blue), overweight (red), obese (green).
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inal obesity.
In men without abdominal obesity, the prevalence of
metabolic health increased linearly, while in those with
abdominal obesity an initial increase in metabolic health
was attenuated after 1999 (Figure 2b). Among women
with or without abdominal obesity the prevalence of
metabolic health increased, reaching the highest level in
2004, and thereafter metabolic health decreased in 2009
(Figure 2c). Time trends were highly significant for all




























Figure 2 Time trends in metabolic health for individuals aged 25–64, b
Normal-weight (red), abdominal obese (blue).Anthropometric predictors of metabolic health in 2009
In 2009, 1719 men and women aged 25 to 74 years par-
ticipated, 69% of those invited. The mean age for the
group with metabolic health was 42 years, and it was 54
for those without metabolic health (p < 0.001). Women
had a 6.5%-units (1.9; 10) higher prevalence of metabolic
health than men, 27.9 vs 21.9% (p = 0.004). After adjust-
ing for age, the odds ratio for metabolic health was 0.73
(0.58; 0.93), comparing men to women. The prevalence
of metabolic health declined with age but increased in
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Figure 3 Prevalence of metabolic health in 10-year age groups
in 2009.
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had metabolic health while less than one fifth of those
with overweight or obesity achieved metabolic health
(Table 1). Adjusting for age and sex, the odds ratios for
metabolic health were 0.54 (95%CI 0.41; 0.72) and 0.59
(95%CI 0.43; 0.82) for overweight and obese subjects,
respectively, compared with normal-weight subjects.
Further adjustment for smoking, physical activity and
education level did not influence the estimates. Similar
proportions and odds ratios were found when compar-
ing those with or without abdominal obesity.
Influence of lifestyle and socioeconomic status
Altogether 18.8% of the smokers in 2009 had meta-
bolic health, compared with 25.8% of the non-smokers
(p = 0.04), a difference of 7.0%-units (0.4; 12). Subjects
with a university level education had 7.7%-units (3.1;
12) higher prevalence of metabolic health, 30.4% com-
pared with 22.8% of those with a non-academic educa-
tion (p = 0.001). These differences were no longerTable 1 Prevalence of metabolic health in 2009 according to





Obesity according to BMI
Normal weight 34.6 Referen
(n = 694) (31; 38)
Overweight 17.5 0.40
(n = 651) (15; 21) (0.31; 0.
Obesity 19.8 0.47
(n = 359) (16; 24) (0.34; 0.
Obesity according to waist circumference
No abdominal obesity 35.1 Referen
(n = 930) (32; 39)
Abdominal obesity 16.5 0.36
(n = 774) (14; 19) (0.29; 0.
Odds ratios and 95% confidence intervals (CI). P values for all comparisons <0.001.significant after adjusting for age and sex. Of those
that exercised once a week or more, 26.6% had meta-
bolic health, compared with 19.5% of those who exer-
cised less than once a week (p = 0.008), a difference of
7.9%-units (2.7; 12). After adjusting for age and sex,
exercising less than once a week was associated with
31% less probability of metabolic health (OR 0.69; CI
0.50; 0.92).
Influence of treatment with lipid lowering agents or
anti-hypertensives
Over the whole period 1986 to 2009, 10.0% of partici-
pants, 25 to 64 years, were treated with anti-hypertensives
(n = 776), lipid lowering drugs (n = 218) or both. In 2009,
23.7% of participants, 25 to 74 years, were treated with
anti-hypertensives (n = 321), lipid lowering drugs (n =
208) or both. Applying the previous definition of meta-
bolic health but categorizing drug treated subjects as not
metabolically healthy, irrespective of their blood pressure
and cholesterol levels, all analyses were repeated. In
general, all prevalence estimates were 2-5%-units lower. In
2009, the prevalence of metabolic health among women
25 to 74 years thus decreased from 27.9% to 24.8% and
among men from 21.9% to 17.0%. The proportion meta-
bolically healthy obese in 2009 using this definition was
15.8% compared to 19.8% with the original definition, cor-
responding estimates among overweight subjects were
13.1% vs 17.5% and among normal weight subjects 31.4 vs
34.6%.
Discussion
We found a large improvement in metabolic health
(defined as having a normal blood pressure, normal





Adjusting for age, sex, smoking,
education and physical activity
ce category Reference category Reference category
0.54 0.52
52) (0.41; 0.72) (0.39; 0.70)
0.59 0.60
62) (0.43; 0.82) (0.43; 0.84)
ce category Reference category Reference category
0.52 0.52
46) (0.41: 0.67) (0.40; 0.67)
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women in the two northernmost counties of Sweden.
However, women were generally healthier than men.
The increase in metabolic health was attenuated after
the turn of the millennium, and the trend was re-
versed after 2004 for normal- and overweight women
and obese and overweight men. Notably we have not
found any previous study reporting long-term trends
in metabolic health in a well-defined population using
a standardized methodology. As recently reviewed
[24], there is no consensus on the definition of meta-
bolic health among the obese. As our focus was to
explore the impact of obesity on CVD risk we choose
to rather use the well- validated risk factors systolic
blood pressure, total cholesterol and absence of dia-
betes. A comparison of prevalence data with other
studies is not possible as the 27 studies reviewed used
30 definitions of metabolic health and prevalence ranged
between 6% and 75%, with strong age dependence.
The MONICA and NHANES studies [2,7] have shown
decreasing CVD risk factors over many years, which are
the underlying forces that drive the increase in meta-
bolic health. Could the decreasing metabolic health from
2000 represent a new development and be related to
changing diets such as the “low carb, high fat” diet
which has received a great deal of attention? Thus, a
long-term and very promising trend towards improved
metabolic health among the obese seems to have been
broken. The recently finished 2014 MONICA survey will
possibly provide some answers.
In 2009, CVD risk factors still accumulated in over-
weight and obese subjects, more so in men than in
women. This indicates that while a larger proportion of
these subjects now are metabolically healthy, it is still
detrimental for one’s health to be overweight and obese,
supporting finds from the Framingham and NHANES
studies [2,12,25]. However, the larger improvement among
the obese may help to explain the paradox of decreasing
CVD while obesity increases.
Abdominal obesity was associated with a lower preva-
lence of metabolic health and higher prevalence of risk
factors for CVD. Despite the fact that the subjects with
abdominal obesity more than doubled their metabolic
health over the 23-year observation period, from 6.4% to
17.3%, it was still half as common for them to be
healthy, compared with those without abdominal obes-
ity. Those without abdominal obesity were as metabolic-
ally healthy as the normal-weight individuals, and those
with abdominal obesity had a similar prevalence of
metabolic health as the overweight or obese individuals.
As been reported in NHANES and other studies [26-28],
abdominal obesity is a better predictor for unhealthiness,
but we could not discern any significant difference in
clustering of the three risk factors, hypertension,cholesterol and diabetes, between the methods of meas-
uring obesity.
Interestingly, in 2009 the obese women had a greater
prevalence of metabolic health than the overweight
women, contrary to the expected pattern seen in men.
This result may be driven by the higher cholesterol
among overweight women compared with the obese, as
cholesterol below 5.0 mmol/l was a criterion for meta-
bolic health. However, we have also previously reported
that between 2004 and 2009, waist circumference de-
creased and hip circumference increased among women
in northern Sweden [3]. It is noteworthy that a protect-
ive effect of larger hip circumference adds considerably
to the predictive value of waist circumference on inci-
dence and mortality of CVD as pointed out in a recent
systematic review [29].
In 2009, those subjects with metabolic health had a
mean age roughly 10 years younger than those without
metabolic health. However, even among the youngest,
less than 60% had metabolic health. In subjects aged 65
years or more, prevalence of metabolic health slightly in-
creased compared to those 55–64 years of age. The ex-
planation for this is unclear. Perhaps retired persons
have more time for exercise and adopt a healthier life-
style today and ignore the latest trends such as “the low
carb, high fat diet”. It is also possible that the health care
system more actively diagnoses and treats hypertension
and hyperlipidemia in the elderly. Younger individuals
may be encouraged to change their lifestyle in lieu of
treatment and may not succeed or have little contact
with their health care center and therefore risk factors
are not assessed.
Smoking was not associated with poorer metabolic
health. However, other studies have shown smoking and
obesity to have a synergistic effect on cardiovascular risk
[25]. With higher education it was more likely for an
individual to be of normal weight and metabolically
healthy, as is supported by two Swedish studies [9,30],
which found that a higher education makes one less
likely to be obese and thus more likely to be metabolic-
ally healthy. However, adjustment for age and sex abol-
ished the difference between education groups, which
supports the idea that life style and primary prevention
in Sweden may not bias the socially disadvantaged as
much as in other countries.
Subjects with regular physical exercise more often had
metabolic health, although less exercise did not explain
less metabolic health in obesity or overweight. In a recent
study [18] fitness was associated with metabolic health in
the obese. Furthermore, fitness was shown to reduce car-
diovascular mortality for overweight and obese individuals
[21]. Since we had no measure of fitness, we used the self-
reported physical activity as a proxy, but still our findings
corroborate those fitness studies.
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Self-reported weight and height are prone to bias [31],
and while questionnaires can provide fairly valid esti-
mates of known diabetes, parameters such as blood
pressure, glucose, waist circumference and cholesterol
need to be measured. Thus, a valid description and ana-
lysis of cardiovascular risk factors, diabetes and their
relationship with obesity, on a population level must be
based on a physical examination of a random sample,
not only on postal questionnaires, which are a common
instrument in public health research.
In the Northern Sweden MONICA study, a strict and
uniform methodology has been used throughout the
whole time period, from 1986 to 2009. Newer methods
of analysis were adjusted after re-running older samples,
and all anthropometric measurements were performed
by trained staff using similar equipment and protocols.
This provides a wealth of highly comparable data from
an extended time period. Both internal and external val-
idity is high, and it is possible to take common con-
founders such as socioeconomic status into consideration.
The major limitation of this study is a declining par-
ticipation rate over the study period. This is most pro-
nounced among the younger population and could
present a problem with selection bias. Telephone inter-
views with the majority of the nonparticipants in the
first three surveys (1986, 1990, 1994) showed that they
were more likely to smoke (despite similar levels of edu-
cation) and less likely to be obese or hypertensive than
the participants. For the 2009 survey, nonparticipants
were younger with lower education and a higher preva-
lence of diabetes and regular smoking. This may lead to
the 2009 data painting an overly optimistic picture, as a
higher prevalence of diabetes and smoking should lower
the amount of metabolically healthy individuals.
Our definition of metabolic health is arbitrary but
based on the most recent European guidelines for car-
diovascular prevention, decided upon by all the relevant
scientific organizations and systematic reviews [23]. We
did not have data on triglyceride or HDL-cholesterol
levels, which could have helped to further refine the
concept of metabolic health but perhaps not adding
much to estimating CVD risk. The variables used were
those that form the basis for the cardiovascular risk
score (SCORE) proposed by the European Society of
Cardiology.
In the definition of metabolic health, treatment for
the included risk factors was not taken into account.
This could be called into question as treatment of these
risk factors probably does not remove all the associated
cardiovascular risk. Therefore, we performed an ancil-
lary analysis by classifying treated subjects as not meta-
bolically healthy even if their blood pressure and
cholesterol levels were normal. The same generalpattern in associations persisted although the absolute
levels were lower, most notably among the obese, as
expected. This sensitivity analysis strengthens our find-
ings. The dichotomization of reported physical activity
may also be a too coarse and blunt instrument to measure
and explore a complicated life style such as physical
activity.
Conclusions
While the prevalence of overweight and obesity is in-
creasing in the population of northern Sweden, we can
for the first time report that a larger proportion within
all weight groups are metabolically healthy over the 23
year observation period. Thus, the strength of obesity
as a CVD risk factor may be attenuated [15]. Frequent
exercise may contribute to making obesity a more be-
nign condition from a cardiovascular point of view.
Surprisingly, being overweight was not substantially dif-
ferent from being obese or having abdominal obesity
regarding metabolic health.
As the improvement in metabolic health is slowing
down and even reversing for some groups, there is still
cause for concern. In addition to traditional cardiovas-
cular risk factors, assessment of cardiorespiratory fit-
ness would be useful to risk stratify individuals with
overweight and obesity. A comprehensive analysis of
these variables would help in risk prediction and indi-
vidualized advice and support in primary prevention of
CVD and diabetes.
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